B
BioNTech SE (BNTX)
NMS – Real Time Price. Currency in USD
93.66
+0.32 (0.34%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
93.66
+0.32 (0.34%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.80 | 6.05 | 10 | |
| Quick ratio | 8.74 | 5.63 | 10 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | -165.28 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 18.19B | 4.13B | 2.98B | 3.24B | 3.26B |
| Gross Profit | 18.03B | 3.51B | 2.39B | 2.51B | 2.39B |
| Operating Income | 15.97B | 979M | -696M | -733M | -921M |
| Net Income | 9.92B | 1.01B | -720M | -1.28B | -1.45B |
| EBITDA | 16.10B | 1.18B | -374M | -301M | -384M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -30.08 | -27.56 | 1.0 |
| Next quarter | -25.44 | 889.52 | 5.5 |
| Current year | -24.06 | 0.66 | 1.5 |
| Next year | 3.4 | -1.8 | 2.5 |
| Weighted average score | 2.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -86.91 | -75.28 | -65.25 | -300.17 | 1.0 |
| Y/Y | -28.17 | -42.19 | -29.63 | 62.03 | 3.3 |
| 3y average | -32.11 | -113.17 | -116.61 | 18.28 | 3.0 |
| 5y average | 772.83 | 13952.04 | 12179.66 | 495.09 | 10 |
| Weighted average score | 4.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Narrow | 4.0 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Medium | 6.0 |
| Network effect | Narrow | 3.0 |
| Economies of scale | Medium | 6.0 |
| Weighted average score | 5.4 | |
Company's cash reserves $11.5B significantly exceed its total debt $348.9M, ensuring strong financial flexibility
Total current assets $17.9B exceed Total current liabilities $2.0B, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-165.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$559.0M limits the company's ability to reinvest or pay down debt